A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Yung, W K A, Albright, R E, Olson, J, Fredericks, R, Fink, K, Prados, M D, Brada, M, Spence, A, Hohl, R J, Shapiro, W, Glantz, M, Greenberg, H, Selker, R G, Vick, N A, Rampling, R, Friedman, H, Phillips, P, Bruner, J, Yue, N, Osoba, D, Zaknoen, S, Levin, V A·2000·British Journal of Cancer

DOI 10.1054/bjoc.2000.1316

Cited by (928)

Items 501–600 of 928

Inhibition of Bevacizumab-induced Epithelial–Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells
Wenqiu Huang, Chenguang Zhang, Mengtian Cui, Jing Niu, Wei Ding · 2017 · Anticancer Research
Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery
Andrea Talacchi, Domenico D’Avella, Luca Denaro, Barbara Santini, Pietro Meneghelli, Silvia Savazzi, Massimo A. Gerosa · 2012 · Journal of Neuro-Oncology
Update on Anti-angiogenic Treatment for Malignant Gliomas
John F. de Groot, Jacob Joseph Mandel · 2014 · Current Oncology Reports
Complications from pharmacotherapy
Burt Nabors, Birgit Surboeck, Wolfgang Grisold · 2016 · Handbook of clinical neurology
Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas
Werner Konrad Strik · 2008 · Molecular Medicine Reports
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group
Sarah Kirby, Stan Z. Gertler, Warren P. Mason, Christopher Watling, Peter A. Forsyth, Jacinta U. Aniagolu, Robert Stagg, Matthew R. Wright, Jean Powers, Elizabeth A. Eisenhauer · 2005 · Neuro-Oncology
Monoclonal Antibody Therapy For Malignant Glioma
Kevin S. Chen, Duane A. Mitchell · 2012 · Advances in experimental medicine and biology
Systemic Temozolomide Combined with Loco-regional Mitoxantrone in Treating Recurrent Glioblastoma
Amerigo Boiardi, Marica Eoli, Andrea Salmaggi, E. Lamperti, A. Botturi, Giovanni Broggi, Lorena Bissola, Gaetano Finocchiaro, Antonio Silvani · 2005 · Journal of Neuro-Oncology
Chemotherapy in the treatment of malignant gliomas
Jennifer I. Stern, Jeffrey J. Raizer · 2006 · Expert Review of Anticancer Therapy
New approaches for temozolomide therapy: Use in newly diagnosed glioma
Roger Stupp, Edward Newlands · 2001 · Seminars in Oncology
Novel Radiation-Enhancing Agents in Malignant Gliomas
Mei Zhang, Arnab Chakravarti · 2005 · Seminars in Radiation Oncology
Cold Plasma Discharge Tube Enhances Antitumoral Efficacy of Temozolomide
Xiaoliang Yao, Dayun Yan, Li Lin, Jonathan H. Sherman, Katherine B. Peters, Stephen Thomas Keir, Michael Keidar · 2022 · ACS Applied Bio Materials
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults
Isabelle M. Germano, Mateo Ziu, Patrick Yung Wen, David Ryan Ormond, Jeffrey J. Olson · 2022 · Journal of Neuro-Oncology
Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma
Alba Ariela Brandes, Enrico Franceschi, Thierry Gorlia, Wolfgang Wick, Andréas H. Jacobs, Brigitta G. Baumert, Martin J. van den Bent, Michael Weller, Roger Stupp · 2011 · European Journal of Cancer
Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation
Hiroyuki Momota, Yoshitaka Nariata, Yasuji Miyakita, Ako Hosono, Atsushi Makimoto, Soichiro Shibui · 2010 · Pediatric Blood & Cancer
Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life
Linda Stöckelmaier, Mirjam Renovanz, J. König, Katrin Nickel, Anne‐Katrin Hickmann, Regine Mayer‐Steinacker, Minou Nadji‐Ohl, Oliver Ganslandt, Lars Bullinger, Christian Rainer Wirtz et al. · 2017 · World Neurosurgery
Health-related quality of life and symptom research in glioblastoma multiforme patients
MARTIN J.B. TAPHOORN, Andrew Bottomley · 2005 · Expert Review of Pharmacoeconomics & Outcomes Research
Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas
Matthias Simon, David Voss, Tjoung‐Won Park‐Simon, Ralph Mahlberg, Gertraud Köster · 2006 · Oncology Reports
Assessing HRQOL: a neglected issue for high-grade glioma
Fabio Efficace, Andrew Bottomley · 2003 · The Lancet Oncology
O 6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: A review of current status
Chitra Sarkar, Vaishali S. Suri, Prerana Jha, Mehar C. Sharma · 2011 · Neurology India
Descriptors for some compounds with pharmacological activity; calculation of properties
Xiangli Liu, William E. Acree, Michael H. Abraham · 2022 · International Journal of Pharmaceutics
Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier
Malik Johid Reza, Anthony T. Podany, Parvez Κhan, Christopher L. Shaffer, Jawed Akhtar Siddiqui, Janina Baranowska‐Kortylewicz, Jennifer Lê, Courtney Vail Fletcher, Sadia Afruz Ether, Sean N. Avedissian · 2023 · Cancer Medicine
Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells.
Albert M. Magro, Alice Magro, C Cunningham, M R Miller · 2007 · PubMed
Approval denied by the European Medicines Agency (EMA) for bevacizumab in the treatment of high-grade glioma recurrence: a good idea or a grave error?
Carmen Balañá, Olatz Etxániz, Cristina Bugés, Alex Martínez‐Martí · 2011 · Clinical & Translational Oncology
Hypersensitivity pneumonitis associated with the use of temozolomide
Dirk Koschel, Sabin Handzhiev, Verena Leucht, Olaf Holotiuk, Annette Fisseler‐Eckhoff, G. Höffken · 2009 · European Respiratory Journal
Efficacy of temozolomide for recurrent embryonal brain tumors in children
Chung‐Hao Wang, Ting‐Rong Hsu, Tai‐Tong Wong, Kai‐Ping Chang · 2008 · Child s Nervous System
Topoisomerase I inhibitors for the treatment of brain tumors
Lynn G. Feun, Niramol Savaraj · 2008 · Expert Review of Anticancer Therapy
Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial
Nikola Mikic, Frantz Rom Poulsen, Kristina B Kristoffersen, R. J. Laursen, Trine Lignell Guldberg, Jane Skjøth‐Rasmussen, Eric T. Wong, S. Møller, Rikke Hedegaard Dahlrot, Jens Christian Hedemann Sørensen et al. · 2021 · BMC Cancer
Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods
Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Alberto Gomes Tavares, Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Marlus Chorilli · 2022 · Current Pharmaceutical Design
Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy
Sunam Mander, Samer A. Naffouje, Jin Gao, Weiguo Li, Konstantin T. Christov, Albert Green, Ernesto Roque Bongarzone, Tapas K. Das Gupta, Tohru Yamada · 2022 · Frontiers in Oncology
Modulating Cancer-Stroma Crosstalk by a Nanoparticle-Based Photodynamic Method to Pave the Way for Subsequent Therapies
Yan Liu, Xiaodi Wu, Feifan Chen, Hao Li, Tao Wang, Ningning Liu, Kang Sun, Guangdong Zhou, Ke Tao · 2022 · Biomaterials
Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme
Mekala Janaki Ramaiah, Kowsalya Adusumilli, Sahiti Chamarthy, Hari Sai Ram Angirekula · 2023 · Metabolic Brain Disease
Chemotherapy and Target Therapy in the Management of Adult High- Grade Gliomas
Gian Paolo Spinelli, Evelina Miele, Giuseppe Lo Russo, Massimo Miscusi, Giovanni Codacci-Pisanelli, Vincenzo Petrozza, Anselmo Papa, Luigi Frati, Carlo Della Rocca, Alberto Gulino et al. · 2012 · Current Cancer Drug Targets
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
Wolfgang Wick, Andriy Krendyukov, Klaus Junge, Thomas Höger, Harald Fricke · 2019 · Journal of Neuro-Oncology
Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens
Kristen A. Batich, John Howard Sampson · 2014 · Expert Opinion on Pharmacotherapy
Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme
Vitaliana De Sanctis, Giorgio Mazzarella, Mattia Falchetto Osti, Maurizio Valeriani, Marco Alfò, Maurizio Salvati, Enzo Banelli, Vincenzo Tombolini, Riccardo Maurizi Enrici · 2006 · Anti-Cancer Drugs
Temozolomide Treatment of an Adult with a Relapsing Medulloblastoma
Xavier Durando, Émilie Thivat, O. Gilliot, B. Irthum, Pierre Verrelle, Catherine Vincent, Jacques‐Olivier Bay · 2007 · Cancer Investigation
Stereotactic Radiosurgery in the Management of Intracranial Gliomas
David Roberge, Luís Souhami · 2003 · Technology in Cancer Research & Treatment
Treatment of Anaplastic Glioma
Wolfgang Wick, Benedikt Wiestler, Michael Platten · 2014 · Cancer treatment and research
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
Marijke B Coomans, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin J. van den Bent, Andrew Bottomley, Alba Ariela Brandes, Olivier Louis Chinot, Corneel Coens, Thierry Gorlia et al. · 2022 · Neuro-Oncology
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma
Mario Balducci, Barbara Diletto, Silvia Chiesa, Giuseppe Roberto D’Agostino, Maria Antonietta Gambacorta, Milena Ferro, Cesare Colosimo, Giulio Maira, Carmelo Anile, Vincenzo Valentini · 2014 · Strahlentherapie und Onkologie
Using bioluminescence imaging in glioma research
Rodney Brian Luwor, Stanley S. Stylli, Andrew Henry Kaye · 2015 · Journal of Clinical Neuroscience
Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
Eric T. Wong, Joshua J. Timmons, Amy Callahan, Lauren O’Loughlin, Bridget Giarusso, David C. Alsop · 2016 · BMC Cancer
Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
Vikram S. Soni, Ted K. Yanagihara · 2019 · Cancer Imaging
Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway
Gabriela Basile Carballo, Diana Matias, Jéssica Honorato Ribeiro, Luciana Santos Pessoa, Ananias Matos Arrais-Neto, Tânia Cristina Leite de Sampaio e Spohr · 2020 · Life Sciences
Anti-Angiogenic and Pro-Apoptotic Effects of Dietary Restriction in Experimental Brain Cancer: Role of Glucose and Ketone Bodies
Thomas N. Seyfried, P Mukherjee · 2005 · Springer eBooks
Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?
Manuela Caroli, Marco Locatelli, Rolando Campanella, Federica Motta, Annarita Mora, Francesco Ugo Prada, Stefano Borsa, Filippo Martinelli Boneschi, Andrea Saladino, Sergio Maria Gaini · 2007 · Journal of Neuro-Oncology
Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
Marco Riva, Francesca Imbesi, Ettore Beghi, C. GALLI, Alberto Citterio, P Trapani, Roberto Sterzi, Massimo Collice · 2007 · PubMed
NOVEL CHEMOTHERAPEUTIC APPROACHES TO BRAIN TUMORS
Edward J. Dropcho · 2001 · Hematology/Oncology Clinics of North America
Combined modality treatment for central nervous system malignancies
H. Ian Robins · 2003 · Seminars in Oncology
Intracranial Metastatic Esthesioneuroblastoma Responsive to Temozolomide
Wolfgang Wick, Antje Wick, Wilhelm Küker, JOHANNES DICHGANS, Michael Weller · 2004 · Journal of Neuro-Oncology
Temozolomide and Radiotherapy as First-Line Treatment of High-Grade Gliomas
Pietro Corsa, Salvatore Parisi, Arcangela Raguso, Michele Troiano, Antonio Perrone, Sabrina Cossa, Tindara Munafò, Michele Piombino, Girolamo Spagnoletti, Francesco Borgia · 2006 · Tumori Journal
Recent therapeutic advances and insights of recurrent glioblastoma multiforme
Juxiang Chen · 2012 · Frontiers in bioscience
Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial
Alex Vils, Marta Bogowicz, Stephanie Tanadini‐Lang, Diem Vuong, Natalia Saltybaeva, Johannes Kraft, Hans‐Georg Wirsching, Dorothee Gramatzki, Wolfgang Wick, Elisabeth Jane Rushing et al. · 2021 · Frontiers in Oncology
Chemotherapy for the treatment of intracranial glioma in dogs
Roberto José‐López · 2023 · Frontiers in Veterinary Science
The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas
Rachel Grossman, Michelle A. Rudek, Harry C. Brastianos, Patti Zadnik, Henry Brem, Betty Tyler, Jaishri O'Neill Blakeley · 2012 · Cancer Chemotherapy and Pharmacology
Advances in malignant glioma drug discovery
David A. Reardon, James Perry, Alba Ariela Brandes, Rakesh Jalali, Wolfgang Wick · 2011 · Expert Opinion on Drug Discovery
Dose-dense Temozolomide: Is It Still Promising?
Motoo Nagane · 2014 · Neurologia medico-chirurgica
Temozolomide and oral etoposide in children with recurrent malignant brain tumors
Antonio Ruggiero, Anna Ariano, Silvia Triarico, Michele Antonio Capozza, Alberto Romano, Palma Maurizi, Stefano Mastrangelo, Giorgio Attinà · 2020 · Drugs in Context
Net clinical benefit: Functional endpoints in brain tumor clinical trials
Terri S. Armstrong, Mark R. Gilbert · 2007 · Current Oncology Reports
The use of chemotherapy in patients with gliomas: Patterns of care in Victoria from 1998–2000
Lawrence Cher, Mark Andrew Rosenthal, Katharine Jann Drummond, Michael J. Dally, Michael Murphy, David L. Ashley, Vicky J. Thursfield, Graham G. Giles · 2008 · Journal of Clinical Neuroscience
Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats
Yuhui Zhang, He Zhang, Jianmin Liu, Zhijian Yue · 2010 · Medical Oncology
Treatment of glioblastoma with herbal medicines
I Trogrlić, Dragan Trogrlić, Amina Kadrić Trogrlić, Amina Kadrić Trogrlić · 2018 · World Journal of Surgical Oncology
Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
Seung-Ho Yang, Moon-Kyu Kim, Tae‐Kyu Lee, Kwan‐Sung Lee, Sin-Soo Jeun, Chun-Kun Park, Joon-Ki Kang, Moon‐Chan Kim, Yong-Kil Hong · 2006 · Journal of Korean Medical Science
Emerging drugs for malignant glioma
Warren P. Mason · 2008 · Expert Opinion on Emerging Drugs
The Outcomes of Concomitant Chemoradiotherapy Followed by Adjuvant Chemotherapy with Temozolomide for Newly Diagnosed High Grade Gliomas : The Preliminary Results of Single Center Prospective Study
Jung-Won Choi, Min Mi Lee, In Ah Kim, Jee Hyun Kim, Gheeyoung Choe, Chae‐Yong Kim · 2008 · Journal of Korean Neurosurgical Society
DNA-binding agents
Yago L. Nieto · 2003 · Cancer chemotherapy and biological response modifiers
Current and Future Trials of the EORTC Brain Tumor Group
Martin J. van den Bent, Roger Stupp, Alba Ariela Brandes, Denis Lacombe · 2004 · Oncology Research and Treatment
Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with High Grade Gliomas
V. Vallejos, Carmen Balañá, Manel Fraile, Yannis Roussos, Jaume Capellades, Patricia Cuadras, R. Ballester, Adolfo Ley, Antonio Arellano, Rafael Rosell · 2002 · Journal of Neuro-Oncology
A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy
Gábor Somlyai, Bea Zs Kovács, András Papp, Ildikó Somlyai · 2023 · Biomedicines
Antitumor Compound Testing in Glioblastoma Organotypic Brain Cultures
Thelma E. Biggs, Janet Foreman, Lars Sundström, Urs Regenass, François Lehembre · 2011 · SLAS DISCOVERY
The Anti-Glioma Effect of Juglone Derivatives through ROS Generation
Jinsen Zhang, Minjie Fu, Jinfeng Wu, Fengfeng Fan, Xin Zhang, Chunjie Li, Hui Yang, Yonghe Wu, Yiming Yin, Wei Hua · 2022 · Frontiers in Pharmacology
Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma
Minoru Tanaka, Nelson Hirokazu Tsuno, Tomoyuki Fujii, Tomoki Todo, Nobuhito Saito, Koki Takahashi · 2012 · Cancer Science
Hemorrhagic Cystitis as an Unexpected Adverse Reaction to Temozolomide
Rezwan Islam, Bart J. Isaacson, Philip M. Zickerman, Chirasakdi Ratanawong, Stuart J. Tipping · 2002 · American Journal of Clinical Oncology
New chemotherapy options for the treatment of malignant gliomas
Riccardo Soffietti, Roberta Rudà, Elisa Trevisan · 2007 · Anti-Cancer Drugs
Cancer Cell Invasion of Brain Tissue: Guided by a Prepattern?
Michael Wurzel, Carlo Schaller, Matthias Simon, Andreas Deutsch · 2004 · Computational and Mathematical Methods in Medicine
In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts
Gilles Vassal, Jean‐Louis Merlin, Marie‐José Terrier‐Lacombe, Jacques Grill, Fabrice Parker, Christian Sainte‐Rose, Geneviève Aubert, Jackie Morizet, Nicolas Sévenet, Marie‐Gwenaelle Poullain et al. · 2003 · Cancer Chemotherapy and Pharmacology
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial
Antje Wick, Anja Sander, Matthew J. Koch, Martin Bendszus, Stephanie Elisabeth Combs, Terry Haut, Andrea Dormann, Stephen D. Walter, Milena Pertz, J. Merkle-Lock et al. · 2022 · BMC Cancer
Updates in the Management of Recurrent Glioblastoma Multiforme
Hanuman Prasad Prajapati, Ahmad Ansari · 2022 · Journal of Neurological Surgery Part A Central European Neurosurgery
Radiothérapie des glioblastomes : de la radiobiologie à la chimiothérapie concomitante
J.-M. Simon, T. Toubiana, Philippe Lang, Sophie Taillibert, J.J. Mazeron · 2005 · Cancer/Radiothérapie
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
Carmen Balañá, M. A. Vaz, D. Lopez, Ramon De Las Peñas Bataller, Jose Maria Garcia-Bueno, María José Molina-Garrido, Juan Manuel Sepúlveda-Sánchez, Juana María Cano, Cristina Bugés, Sandra Sanz et al. · 2013 · Clinical & Translational Oncology
New developments in the treatment of malignant gliomas
Riccardo Soffietti, Barbara Leoncini, Roberta Rudà · 2007 · Expert Review of Neurotherapeutics
New Chemotherapy Treatments in Advanced Cancer Patients An Easily Applicable Evaluation of Clinical Efficacy and Cost–effectiveness
José Expósito, Jorge Hernández, Amalia Fernández Feijoó, Teresa Nieto, Eduardo Briones · 2003 · Acta Oncologica
Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial
Xuetao Li, Xiaoyun Shang, Jiangang Liu, Yang Zhang, Xian Jia, Huabing Li, Yihan Wang, Jianen Gao, Xu Ma, X H Zhang et al. · 2026 · Nature Communications
Anti-vascular endothelial growth factor therapy in the era of personalized medicine
Luis Roberto Féliz, Apostolia Maria Tsimberidou · 2013 · Cancer Chemotherapy and Pharmacology
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme1
Michael Badruddoja, Kara Penne, Annick Desjardins, David A. Reardon, Jeremy N. Rich, Jennifer A. Quinn, Sith Sathornsumetee, Allan H. Friedman, Darell D. Bigner, James E. Herndon et al. · 2006 · Neuro-Oncology
The Role of Chemotherapy in the Treatment of Malignant Astrocytomas
David Mathieu, David Fortin · 2006 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis
Jennifer Cohn Kesselheim, Andrew David Norden, Patrick Yung Wen, Steven Joffe · 2011 · The Oncologist
Effect of alternative temozolomide schedules on glioblastoma O6-methylguanine-DNA methyltransferase activity and survival
Clifford G. Robinson, J M Palomo, Gazanfar Rahmathulla, Mary McGraw, Jon R. Donze, L Liu, Michael A. Vogelbaum · 2010 · British Journal of Cancer
The Effect of Enzyme-Inducing Antiseizure Drugs on the Pharmacokinetics and Tolerability of Procarbazine Hydrochloride
Stuart A. Grossman, Kathryn A. Carson, Tracy T. Batchelor, Glenn Jay Lesser, Tom Mikkelsen, Jane Β. Alavi, Surasak Phuphanich, Tarek Hammour, Joy D. Fisher, Jeffrey G. Supko · 2006 · Clinical Cancer Research
Optimizing Therapy for Patients With Brain Metastases
T. Kuo, Lawrence David Recht · 2006 · Seminars in Oncology
Chemotherapy of anaplastic oligodendroglial tumours
Riccardo Soffietti · 2004 · Expert Opinion on Pharmacotherapy
Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma
Jinxin Lan, Yuyang Liu, Junyi Chen, Hongyu Liu, Yaping Feng, Jialin Liu, Ling Chen · 2024 · CNS Neuroscience & Therapeutics
Temozolomide for the Treatment of Recurrent Supratentorial Glioma: Results of a Compassionate use Program in Belgium
Els Grieta Everaert, Bart Neyns, Eric J. Joosens, Theo Strauven, Fabrice Branle, Johan J Menten · 2004 · Journal of Neuro-Oncology
RADIATION THERAPY ONCOLOGY GROUP RTOG 0825 PHASE III DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE PLUS BEVACIZUMAB VERSUS CONVENTIONAL CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Holcombe Blvd, Minesh P. Mehta, Ken Aldape, Howard Colman, Terri S. Armstrong, Jeffrey Scott Wefel · 2009
Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
Jingjing Ge, Cheng Li, Fengjun Xue, Shaopei Qi, Zhi-meng Gao, Chunjiang Yu, Junping Zhang · 2021 · Frontiers in Oncology
Clinical Manifestations and Diagnostic Imaging of Brain Tumors
Bart P. Keogh, John W. Henson · 2012 · Hematology/Oncology Clinics of North America
The temozolomide derivative 2T-P400 inhibits glioma growth via administration route of intravenous injection
Rujun Li, Dongfang Tang, Jinshi Zhang, Jinding Wu, Ling Wang, Jun Dong · 2013 · Journal of Neuro-Oncology
A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme
Tomokazu Aoki, Tomohiko Mizutani, Masatsune Ishikawa, Kazuhiko Sugiyama, Nobuo Hashimoto · 2003 · International Journal of Clinical Oncology
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas
Gaurav Shah, Joel S. Silver, Steven S. Rosenfeld, Igor T. Gavrilovic, Lauren E. Abrey, Andrew B. Lassman · 2007 · Journal of Neuro-Oncology